Page last updated: 2024-10-28

miltefosine and B-Cell Chronic Lymphocytic Leukemia

miltefosine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Teh, JSK1
Tam, PCK1
Badenoch, PR1
Adamson, PJ1
Brennan, C1
Marshman, G1
Gordon, DL1
Gee, SN1
Rothschild, B1
Click, J1
Sheth, V1
Saavedra, A1
Hsu, MY1

Other Studies

2 other studies available for miltefosine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib.
    The Journal of antimicrobial chemotherapy, 2022, 02-02, Volume: 77, Issue:2

    Topics: Acanthamoeba castellanii; Adenine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylcholine

2022
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
    Archives of dermatology, 2011, Volume: 147, Issue:7

    Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucy

2011